Drug intelligence / Profile preview

Palpal

Development stage
Unknown
Lead developer
Hanmi Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Palpal is a chewable tablet formulation of sildenafil citrate developed by Hanmi Pharmaceutical for the treatment of erectile dysfunction. It functions as a potent and selective inhibitor of cGMP-specific phosphodiesterase type 5 (PDE5), the enzyme responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. By preventing cGMP breakdown, Palpal enhances the vasodilatory effects of nitric oxide, leading to smooth muscle relaxation and increased blood flow to the penis during sexual stimulation. This chewable version was developed to provide a more convenient administration option compared to traditional oral tablets and has become a leading generic sildenafil product in the South Korean market.

Brand names
Palpal
Other names
sildenafil citratePalpal-jeongsildenafil chewable tablet
02

Targets

PDE5 (Phosphodiesterase 5A)

Beyond the preview

Go deeper on Palpal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Palpal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call